https://comparerx.org/news/novo-ceo-evaluates-nyse-direct-listing CompareRx.org en 2026-09-24T12:15:25.976Z Novo evaluates NYSE direct listing — what the corporate move changes for US GLP-1 buyers https://comparerx.org/news/roche-oral-obesity-drug-ct996-matches-injectables CompareRx.org en 2026-09-24T08:15:30.761Z Roche oral obesity pill CT-996 matches injectable weight loss — challenging the cash-pay telehealth market https://comparerx.org/news/fierce-pharma-launches-oral-glp1-tracker-foundayo-wegovy-pill CompareRx.org en 2026-09-24T04:15:27.256Z Fierce Pharma launches oral GLP-1 tracker — what it changes for telehealth buyers https://comparerx.org/news/fda-warns-empower-pharmacy-compounded-glp1-safety-risks CompareRx.org en 2026-09-24T00:15:31.122Z FDA warns Empower Pharmacy over mass-produced GLP-1s — closing the telehealth compounding loophole https://comparerx.org/news/eli-lilly-70-percent-medicare-glp1-share CompareRx.org en 2026-09-23T20:15:27.993Z Lilly claims 70% share of Medicare GLP-1 program — what it means for cash buyers